AI assistant
Sending…
PRECISION BIOSCIENCES INC — Director's Dealing 2019
Mar 27, 2019
34491_dirs_2019-03-27_fb5be04b-30d3-41ff-8a71-4924a993fb96.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2019-03-27
Reporting Person: FMR LLC (10% Owner, See Remark 1)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Series A Preferred Stock | $ | Common Stock (3279170) | Indirect | ||
| Series B Preferred Stock | $ | Common Stock (409078) | Indirect |
Footnotes
F1: The Series A Preferred Stock and Series B Preferred Stock are convertible on a 1-for-2.134686 basis into the number of shares of Common Stock as shown in column 3 at any time at the holder's election, and automatically upon the closing of the Issuer's initial public offering without payment or further consideration, and have no expiration date.
More from PRECISION BIOSCIENCES INC
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 26
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 8
Proxy Solicitation & Information Statement
2026
Apr 8
Regulatory Filings
2026
Mar 17
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19